Log in to save to my catalogue

Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis...

Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5b73237def4f4bbbba59d86eb965c4a6

Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis and Rheumatology Research Alliance Registry

About this item

Full title

Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis and Rheumatology Research Alliance Registry

Publisher

Boston, USA: Wiley Periodicals, Inc

Journal title

ACR Open Rheumatology, 2022-11, Vol.4 (11), p.954-963

Language

English

Formats

Publication information

Publisher

Boston, USA: Wiley Periodicals, Inc

More information

Scope and Contents

Contents

Objective
Black and Hispanic children with pediatric lupus (pSLE) have higher morbidity and mortality than non‐Hispanic White children. The extent to which differences in outcomes are due to treatment disparities, including medication use, is unknown. We aimed to determine whether medication use in pSLE is associated with race and ethnicity in t...

Alternative Titles

Full title

Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis and Rheumatology Research Alliance Registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5b73237def4f4bbbba59d86eb965c4a6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5b73237def4f4bbbba59d86eb965c4a6

Other Identifiers

ISSN

2578-5745

E-ISSN

2578-5745

DOI

10.1002/acr2.11494

How to access this item